Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688114 · ClinicalTrials.gov registry record · NA
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
A NA study, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02688114: Completed NA study, sponsored by Dallas VA Medical Center.
NCT02688114 is a NA study that has completed, run by Dallas VA Medical Center. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02688114, a NA study, has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Radiofrequency ablation (RFA) is a mainstay of treatment for patients who have Barrett's esophagus (BE) with dysplasia. For unclear reasons, Barrett's esophagus recurs after successful RFA treatment in approximately 1/3 of patients. The aim of this study is to characterize the healing process of the esophageal mucosa, histologically and at the molecular level, after RFA for non-dysplastic and dysplastic Barrett's esophagus.
Primary Outcome
% of the esophageal mucosa healed by Neosquamous epithelium at 1 week, 2 weeks, and 4 weeks after RFA
Interventions
- PROCEDURE Radiofrequency ablation
- PROCEDURE Baseline surveillance endoscopy
- PROCEDURE Follow up endoscopy 1
- PROCEDURE Follow up endoscopy 2
- PROCEDURE Follow up endoscopy 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-10-18 |
| Est. Completion | 2020-01-29 |
| Phase | NA |
What the finished NCT02688114 record still lists
NCT02688114 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Radiofrequency ablation is the first listed.
NCT02688114 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02688114 about?
NCT02688114 is a clinical study titled "Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus". Radiofrequency ablation (RFA) is a mainstay of treatment for patients who have Barrett's esophagus (BE) with dysplasia. For unclear reasons, Barrett's esophagus recurs after successful RFA treatment in approximately 1/3 of patients. The aim of this study is to characterize the healing process of the...
What is the current status of trial NCT02688114?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-10-18. Estimated completion is 2020-01-29.
What interventions are being tested in trial NCT02688114?
The interventions under investigation include: Radiofrequency ablation (PROCEDURE), Baseline surveillance endoscopy (PROCEDURE), Follow up endoscopy 1 (PROCEDURE), Follow up endoscopy 2 (PROCEDURE), Follow up endoscopy 3 (PROCEDURE).
Who is sponsoring clinical trial NCT02688114?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02688114's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI